Fingerprint
Dive into the research topics where Dung Le is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer
Le, D. T., Folprecht, G., Varghese, A. M., Gutierrez, M., Noel, M., Trikalinos, N. A., Chen, E., Dayyani, F., Davis, L. L., Ma, W. W., BasuMallick, A., Garrido-Laguna, I., Osawa, M., O’Brien, S., Novosiadly, R. D., Xu, K., Greenawalt, D. M., Dutta, S., Twyman Saint Victor, C. & Lenz, H. J., Jan 22 2026, In: Journal for immunotherapy of cancer. 14, 1, e011284.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages
Bever, K. M., Shin, S. M., Durham, J. N., Qi, H., Hernandez, A., Coyne, E. M., Gross, N. E., Charmsaz, S., Suresh Babu, J., Vargas Carvajal, D. C., Verma, R., Sun, Y., Zhang, Z., Yuan, X., Cannon, C. D., Hughes, S. N., Mitchell, S., Figlewski, M., Leatherman, J. M. & Wang, H. & 4 others, , 2025, In: OncoImmunology. 14, 1, 2543614.Research output: Contribution to journal › Article › peer-review
Open Access -
Correction: Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair–Proficient Colorectal Cancer (Clin. Cancer Res, (2025) 31, (5317), 10.1158/1078-0432.CCR-25-0002)
Christenson, E. S., Ho, W. J., Shu, D., Durham, J. N., Brancati, M., Bruning, H. D., Petrie, S., Wang, H., Lu, J., Bever, K. M., Laheru, D., de Jesus-Acosta, A., Browner, I., Donehower, R., Pishvaian, M. J., Azad, N., Zhu, Q., Valentin, A., Babu, J. S. & Hernandez, A. & 8 others, , Dec 15 2025, In: Clinical Cancer Research. 31, 24, p. 5317 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Incidence, demographics, and survival of patients with brain metastases from stage IV colorectal cancer: a population-based study from 2013 to 2023
Alfonzo Horowitz, M., Li, M., Parker, M., Arbuiso, A., Gensler, R., Sahebjam, S., Redmond, K. J., Le, D., Gabre-Kidan, A., Azad, N., Bettegowda, C. & Rincon-Torroella, J., Oct 2025, In: Journal of neuro-oncology. 175, 1, p. 123-131 9 p.Research output: Contribution to journal › Article › peer-review
-
Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the ugly
Adashek, J. J., Moran, J. A., Le, D. T. & Kurzrock, R., Jun 2025, In: Cancer and Metastasis Reviews. 44, 2, 43.Research output: Contribution to journal › Short survey › peer-review
Open Access